Sign In
Buy EXEL
$56.04
-0.460 (-0.81%)
At Close: Jul 13, 2026
Biotech Stock Roundup: ALXN, MRNA Up on Coronavirus Treatment Updates, & More
02:30pm, Wednesday, 22'nd Apr 2020
The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.
